For Pfizer Canada, strong alliances with leading research institutions, academics, hospitals and biopharmaceutical laboratories are the backbone of creating meaningful R&D programs with the potential to treat illness and help Canadians live healthier lives.
R&D alliances identify, nurture and develop collaborations that can help accelerate the important work of Canadian scientists. Pfizer Canada's goal is to co-create bridges between the private and public sectors. This ensures that promising medical discoveries receive the kind of corporate support necessary to advance research beyond the laboratory.
Pfizer Canada strives to be a valued member of Canada's R&D infrastructure through participation and commitment in organizations such as: BioteCanada, Canada's Research-Based Pharmaceutical Companies (Rx&D), Canadian Institutes of Health Research (CIHR), Fonds de la recherche en santé du Québec (FRSQ), Centre for Drug Research and Development (CDRD), Centres of Excellence for Commercialization and Research (CECR), BioQuebec and BC Life Sciences.
You are now leaving the Pfizer.ca website.
Pfizer Canada accepts no responsibility for the content of linked sites.